Black Hairy Tongue as a Rare Adverse Effect of Linezolid in Multidrug‐Resistant Tuberculosis: A Case Report

Black hairy tongue (BHT), or lingua villosa nigra, is a rare adverse effect of linezolid, an antibiotic frequently used in the treatment of multidrug-resistant tuberculosis (MDR-TB). We present a case of a 24-year-old female who developed BHT while receiving linezolid as part of a longer regimen for MDR-TB. The patient exhibited a typical BHT presentation, with painless brown-to-black discoloration on the posterior dorsal surface of her tongue, appearing 25 days after initiating linezolid therapy. There were no other identifiable contributing factors. Upon discontinuation of linezolid and a shift to a modified regimen, the BHT completely resolved within 10 days. A Naranjo Adverse Drug Reaction Probability Scale score of 5 suggested a probable causal relationship between linezolid and BHT. This report represents the first documented case of linezolid-associated BHT from Nepal, highlighting the importance of clinicians' awareness of this rare but clinically significant side effect, especially within the context of MDR-TB treatment, to provide prompt diagnosis, reassurance, and appropriate management.

Authors

Institutions

Publication Details

Journal
Clinical Case Reports
Published
2025-09-01
DOI
https://doi.org/10.1002/ccr3.70868
Primary Topic
Oral Health Pathology and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Black Hairy Tongue as a Rare Adverse Effect of Linezolid in Multidrug‐Resistant Tuberculosis: A Case Report

Sanjaya Paudel, Dipendra Adhikari, Maala Bhatt, Sushil Dahal et al.
Clinical Case Reports
Oral Health Pathology and Treatment
article

Black Hairy Tongue as a Rare Adverse Effect of Linezolid in Multidrug‐Resistant Tuberculosis: A Case Report

Sanjaya Paudel, Dipendra Adhikari, Maala Bhatt, Sushil Dahal, Binod Adhikari, A. K. Gautam, Munna William
article en

Abstract

Black hairy tongue (BHT), or lingua villosa nigra, is a rare adverse effect of linezolid, an antibiotic frequently used in the treatment of multidrug-resistant tuberculosis (MDR-TB). We present a case of a 24-year-old female who developed BHT while receiving linezolid as part of a longer regimen for MDR-TB. The patient exhibited a typical BHT presentation, with painless brown-to-black discoloration on the posterior dorsal surface of her tongue, appearing 25 days after initiating linezolid therapy. There were no other identifiable contributing factors. Upon discontinuation of linezolid and a shift to a modified regimen, the BHT completely resolved within 10 days. A Naranjo Adverse Drug Reaction Probability Scale score of 5 suggested a probable causal relationship between linezolid and BHT. This report represents the first documented case of linezolid-associated BHT from Nepal, highlighting the importance of clinicians' awareness of this rare but clinically significant side effect, especially within the context of MDR-TB treatment, to provide prompt diagnosis, reassurance, and appropriate management.

Clinical Case ReportsVol. 13(9)
Nishtar Medical College and Hospital (PK), Bir Hospital (NP), Tribhuvan University Teaching Hospital (NP)
Openalex Percentile: Top 73%
Oral Health Pathology and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.